Glucose-galactose malabsorption
Glucose-galactose malabsorption is a rare genetic metabolic disorder characterized by the body's inability to properly absorb glucose and galactose from the gut. The condition is caused by mutations in the SLC5A1 gene and is inherited in an autosomal recessive manner.
Symptoms[edit | edit source]
The symptoms of glucose-galactose malabsorption typically become apparent in the first few weeks of life. These may include severe diarrhea, dehydration, failure to thrive, and malnutrition. If untreated, the condition can lead to life-threatening complications.
Causes[edit | edit source]
Glucose-galactose malabsorption is caused by mutations in the SLC5A1 gene. This gene provides instructions for producing a protein that is involved in the absorption of glucose and galactose in the intestines. Mutations in the SLC5A1 gene disrupt the function of this protein, preventing the absorption of these sugars and leading to the symptoms of glucose-galactose malabsorption.
Diagnosis[edit | edit source]
The diagnosis of glucose-galactose malabsorption is typically made based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and specialized tests. These tests may include a stool analysis to detect the presence of glucose, and a biopsy of the small intestine to examine the cells that absorb nutrients.
Treatment[edit | edit source]
The treatment of glucose-galactose malabsorption involves a specialized diet that is free of glucose and galactose. This diet allows for the proper absorption of other nutrients and helps to alleviate the symptoms of the condition. In some cases, medications may be used to manage symptoms.
Prognosis[edit | edit source]
With early diagnosis and appropriate dietary management, individuals with glucose-galactose malabsorption can lead healthy lives. However, without treatment, the condition can lead to severe malnutrition and life-threatening complications.
See also[edit | edit source]
| Glucose-galactose malabsorption Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
